The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.

About Followers

Latest preprint reviews

  1. A single-cell and spatial atlas of autopsy tissues reveals pathology and cellular targets of SARS-CoV-2

    1. Toni M. Delorey
    2. Carly G. K. Ziegler
    3. Graham Heimberg
    4. Rachelly Normand
    5. Yiming Yang
    6. Asa Segerstolpe
    7. Domenic Abbondanza
    8. Stephen J. Fleming
    9. Ayshwarya Subramanian
    10. Daniel T. Montoro
    11. Karthik A. Jagadeesh
    12. Kushal K. Dey
    13. Pritha Sen
    14. Michal Slyper
    15. Yered H. Pita-Juárez
    16. Devan Phillips
    17. Zohar Bloom-Ackerman
    18. Nick Barkas
    19. Andrea Ganna
    20. James Gomez
    21. Erica Normandin
    22. Pourya Naderi
    23. Yury V. Popov
    24. Siddharth S. Raju
    25. Sebastian Niezen
    26. Linus T.-Y. Tsai
    27. Katherine J. Siddle
    28. Malika Sud
    29. Victoria M. Tran
    30. Shamsudheen K. Vellarikkal
    31. Liat Amir-Zilberstein
    32. Deepak S. Atri
    33. Joseph Beechem
    34. Olga R. Brook
    35. Jonathan Chen
    36. Prajan Divakar
    37. Phylicia Dorceus
    38. Jesse M. Engreitz
    39. Adam Essene
    40. Donna M. Fitzgerald
    41. Robin Fropf
    42. Steven Gazal
    43. Joshua Gould
    44. John Grzyb
    45. Tyler Harvey
    46. Jonathan Hecht
    47. Tyler Hether
    48. Judit Jane-Valbuena
    49. Michael Leney-Greene
    50. Hui Ma
    51. Cristin McCabe
    52. Daniel E. McLoughlin
    53. Eric M. Miller
    54. Christoph Muus
    55. Mari Niemi
    56. Robert Padera
    57. Liuliu Pan
    58. Deepti Pant
    59. Carmel Pe’er
    60. Jenna Pfiffner-Borges
    61. Christopher J. Pinto
    62. Jacob Plaisted
    63. Jason Reeves
    64. Marty Ross
    65. Melissa Rudy
    66. Erroll H. Rueckert
    67. Michelle Siciliano
    68. Alexander Sturm
    69. Ellen Todres
    70. Avinash Waghray
    71. Sarah Warren
    72. Shuting Zhang
    73. Daniel R. Zollinger
    74. Lisa Cosimi
    75. Rajat M. Gupta
    76. Nir Hacohen
    77. Winston Hide
    78. Alkes L. Price
    79. Jayaraj Rajagopal
    80. Purushothama Rao Tata
    81. Stefan Riedel
    82. Gyongyi Szabo
    83. Timothy L. Tickle
    84. Deborah Hung
    85. Pardis C. Sabeti
    86. Richard Novak
    87. Robert Rogers
    88. Donald E. Ingber
    89. Z. Gordon Jiang
    90. Dejan Juric
    91. Mehrtash Babadi
    92. Samouil L. Farhi
    93. James R. Stone
    94. Ioannis S. Vlachos
    95. Isaac H. Solomon
    96. Orr Ashenberg
    97. Caroline B.M. Porter
    98. Bo Li
    99. Alex K. Shalek
    100. Alexandra-Chloé Villani
    101. Orit Rozenblatt-Rosen
    102. Aviv Regev

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Eicosanoid signaling as a therapeutic target in middle-aged mice with severe COVID-19

    1. Lok-Yin Roy Wong
    2. Jian Zheng
    3. Kevin Wilhelmsen
    4. Kun Li
    5. Miguel E. Ortiz
    6. Nicholas J. Schnicker
    7. Alejandro A. Pezzulo
    8. Peter J. Szachowicz
    9. Klaus Klumpp
    10. Fred Aswad
    11. Justin Rebo
    12. Shuh Narumiya
    13. Makoto Murakami
    14. David K. Meyerholz
    15. Kristen Fortney
    16. Paul B. McCray
    17. Stanley Perlman

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Assessing the utility of lymphocyte count to diagnose COVID-19

    1. Michael Fralick
    2. Orly Bogler
    3. Daniel Tamming
    4. Lauren Lapointe-Shaw
    5. Janice Kwan
    6. Terence Tang
    7. Shail Rawal
    8. Jessica Liu
    9. Farad Razak
    10. Amol A Verma

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. The other COVID ‐19 survivors: Timing, duration, and health impact of post‐acute sequelae of SARS‐CoV ‐2 infection

    1. Natalie Lambert
    2. Survivor Corps
    3. Sarah A. El‐Azab
    4. Nathan S. Ramrakhiani
    5. Anthony Barisano
    6. Lu Yu
    7. Kaitlyn Taylor
    8. Álvaro Esperança
    9. Christian Mendiola
    10. Charles A. Downs
    11. Heather L. Abrahim
    12. Thomas Hughes
    13. Amir M. Rahmani
    14. Jessica L. Borelli
    15. Rana Chakraborty
    16. Melissa D. Pinto

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial

    1. Neil Formica
    2. Raburn Mallory
    3. Gary Albert
    4. Michelle Robinson
    5. Joyce S. Plested
    6. Iksung Cho
    7. Andreana Robertson
    8. Filip Dubovsky
    9. Gregory M. Glenn
    10. for the 2019nCoV-101 Study Group

    Reviewed by ScreenIT, NCRC

    2 evaluationsAppears in 3 listsLatest version Latest activity

  6. Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection

    1. Zaigham Abbas Rizvi
    2. Rajdeep Dalal
    3. Srikanth Sadhu
    4. Akshay Binayke
    5. Jyotsna Dandotiya
    6. Yashwant Kumar
    7. Tripti Shrivastava
    8. Sonu Kumar Gupta
    9. Suruchi Aggarwal
    10. Manas Ranjan Tripathy
    11. Deepak Kumar Rathore
    12. Amit Kumar Yadav
    13. Guruprasad R Medigeshi
    14. Amit Kumar Pandey
    15. Sweety Samal
    16. Shailendra Asthana
    17. Amit Awasthi

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  7. Clinical validation of RCSMS: a rapid and sensitive CRISPR-Cas12a test for the molecular detection of SARS-CoV-2 from saliva

    1. Joaquín Abugattás Núñez del Prado
    2. Angélica Quintana Reyes
    3. Juan Blume La Torre
    4. Renzo Gutiérrez Loli
    5. Alejandro Pinzón Olejua
    6. Elena Rocío Chamorro Chirinos
    7. Félix Antonio Loza Mauricio
    8. Jorge L. Maguiña
    9. Julio Leon
    10. Piere Rodríguez Aliaga
    11. Edward Málaga Trillo

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients

    1. Arne Sattler
    2. Eva Schrezenmeier
    3. Ulrike A. Weber
    4. Alexander Potekhin
    5. Friederike Bachmann
    6. Henriette Straub-Hohenbleicher
    7. Klemens Budde
    8. Elena Storz
    9. Vanessa Proß
    10. Yasmin Bergmann
    11. Linda M.L. Thole
    12. Caroline Tizian
    13. Oliver Hölsken
    14. Andreas Diefenbach
    15. Hubert Schrezenmeier
    16. Bernd Jahrsdörfer
    17. Tomasz Zemojtel
    18. Katharina Jechow
    19. Christian Conrad
    20. Sören Lukassen
    21. Diana Stauch
    22. Nils Lachmann
    23. Mira Choi
    24. Fabian Halleck
    25. Katja Kotsch

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Serological surveys to estimate cumulative incidence of SARS-CoV-2 infection in adults (Sero-MAss study), Massachusetts, July–August 2020: a mail-based cross-sectional study

    1. Teah Snyder
    2. Johanna Ravenhurst
    3. Estee Y Cramer
    4. Nicholas G Reich
    5. Laura Balzer
    6. Dominique Alfandari
    7. Andrew A Lover

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Emergence of the novel SARS-CoV-2 lineage P.4.1 and massive spread of P.2 in South Brazil

    1. Fernando Hayashi Sant’Anna
    2. Ana Paula Muterle Varela
    3. Janira Prichula
    4. Juliana Comerlato
    5. Carolina Baldisserotto Comerlato
    6. Vinicius Serafini Roglio
    7. Gerson Fernando Mendes Pereira
    8. Flávia Moreno
    9. Adriana Seixas
    10. Eliana Márcia Wendland

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Newer Page 2237 of 2361 Older